Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

H Ludwig; H Kasparu; R Greil; C Leitgeb; E Muldur; E Rauch; N Zojer; EM Autzinger; Werner Linkesch; T Kuhr; L Pour; Z Adam

doi:10.1182/blood.V120.21.943.943

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

H Ludwig
, H Kasparu
, R Greil
, C Leitgeb
, E Muldur
, E Rauch
, N Zojer
, EM Autzinger
, Werner Linkesch
, T Kuhr
, L Pour
, Z Adam

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

4 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Blood
DOIs	https://doi.org/10.1182/blood.V120.21.943.943
Publikationsstatus	Veröffentlicht - 2012
Veranstaltung	54th Annual Meeting of the American Society of Hematology - Atlanta, USA/Vereinigte Staaten Dauer: 8 Dez. 2012 → 11 Dez. 2012

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1182/blood.V120.21.943.943

Andere Dateien und Links

Web of Science

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
Ludwig, H. (Autor*in), Kasparu, H. (Autor*in), Greil, R. (Autor*in), Leitgeb, C. (Autor*in), Muldur, E. (Autor*in), Rauch, E. (Autor*in), Zojer, N. (Autor*in), Autzinger, E. (Autor*in), Linkesch, W. (Autor*in), Kuhr, T. (Autor*in), Pour, L. (Autor*in) & Adam, Z. (Autor*in)
2012
Aktivität: Vortrag oder Poster › Wissenschaftliche Vortrag oder Präsentation › vor Ort

Dieses zitieren

@article{8abd2029584e4fdda312705e2039590d,

title = "Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.",

author = "H Ludwig and H Kasparu and R Greil and C Leitgeb and E Muldur and E Rauch and N Zojer and EM Autzinger and Werner Linkesch and T Kuhr and L Pour and Z Adam",

year = "2012",

doi = "10.1182/blood.V120.21.943.943",

language = "English",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "54th Annual Meeting of the American Society of Hematology, ASH 54 ; Conference date: 08-12-2012 Through 11-12-2012",

}

TY - JOUR

T1 - Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

AU - Ludwig, H

AU - Kasparu, H

AU - Greil, R

AU - Leitgeb, C

AU - Muldur, E

AU - Rauch, E

AU - Zojer, N

AU - Autzinger, EM

AU - Linkesch, Werner

AU - Kuhr, T

AU - Pour, L

AU - Adam, Z

PY - 2012

Y1 - 2012

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000313838902018

U2 - 10.1182/blood.V120.21.943.943

DO - 10.1182/blood.V120.21.943.943

M3 - Conference abstract

SN - 0006-4971

JO - Blood

JF - Blood

T2 - 54th Annual Meeting of the American Society of Hematology

Y2 - 8 December 2012 through 11 December 2012

ER -

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

Wissenschaftszweige

Zugriff auf Dokument

Andere Dateien und Links

Aktivitäten

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

Dieses zitieren